Jefferies Raises PT On Express Scripts To $69

February 17, 2011 8:26 AM | 8 seconds read |
Jefferies & Company has raised the price target on Express Scripts ESRX from $57.50 to $69 and maintains its Buy rating.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Price TargetAnalyst Ratingsexpress scriptsHealth CareHealth Care ServicesJefferies & Company
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!